1
Back
J

Journal of Experimental and Clinical Cancer Research

IF12.8
Papers4351
Citations28525
Journal Papers 6135
Publication Date
TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation
delete2025-12-29
delete0
deleteOAAI
deleteHan Wu; Guoqing Zhu; Qianshu Zhu; Ji Ma; Siwei Mao; Miao Ding; Jiabei Zhu; Xiaochen Tang; Zhixuan Bian; Yuhua Shan; Song Gu; Fenyong Sun; Cizhong Jiang; Qiuhui Pan
deleteShare
deleteSave
Challenges and opportunities of human iPSC-derived NK as “Off-the-shelf” cellular therapies
delete2025-12-29
delete0
deleteOAAI
deleteNicola Romanini; Ratchapong Netsrithong; Maria Themeli; Marcella Tazzari
deleteShare
deleteSave
Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer
delete2025-12-29
delete0
deleteOAAI
deleteTanvi Varadkar; Zhuoxin Zora Zhou; Jiashuai Zhang; Anusua Sarkar; Zhantao Du; Srijita Chowdhury; Hwayeon Lim; Lufang Zhou; Xiaoguang Margaret Liu
deleteShare
deleteSave
Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma
delete2025-12-26
delete0
deleteOAAI
deleteStefania Elena Navone; Giovanni Marfia; Laura Guarnaccia; Massimiliano Rizzaro; Giorgio Fiore; Rolando Campanella; Chiara Gaudino; Daniele Santini; Giovanni Andrea Alotta; Monica Rosa Miozzo; Emanuela Barilla; Marco Locatelli; Laura Riboni
deleteShare
deleteSave
USP43 promotes gemcitabine resistance by regulating cholesterol homeostasis through E2F1 stabilization in bladder cancer
delete2025-12-23
delete0
deleteOAAI
deleteMingxing Li; Tianyun Liu; Jiageng Shi; Fenfang Zhou; Zhao Deng; Yongwen Luo; Sheng Tu; Wenyu Jiang; Gang Wang; Kaiyu Qian; Yi Zhang; Yu Xiao; Xinghuan Wang; Tongzu Liu; Lingao Ju
deleteShare
deleteSave
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer
delete2025-12-20
delete0
deleteOAAI
deleteMatteo Allegretti; David J. Joun; Giulia Urbani; Valentina De Pascale; Federica Ganci; Raul Pellini; Giada Anna Beltramini; Stefano Ferrero; Stefano Fiori; Tania Moccia; Chiara Ciardiello; Elena Di Gennaro; Alfredo Budillon; Luca Sigalotti; Roberta Maestro; Mario Urtis; Eloisa Arbustini; Simona De Summa; Amalia Azzariti; Stella Gagliardi; Antonio Pisani; Gennaro Ciliberto; Paola Cornelia Maria Muti; Junko F. Stevens; Giovanni Blandino
deleteShare
deleteSave
SGSS05-NS3, a covalent SETD8 inhibitor that activates p53 pathway in neuroblastoma
delete2025-12-19
delete0
deleteOAAI
deleteZhihui Liu; Sukriti Bagchi; Chunhua Yan; Ying Hu; Gil Blum; Anqi Ma; Jian Jin; Minkui Luo; Sebastiano Di Bella; Francesco Verona; Ettore Appella; Giuseppe Giannini; Carol J. Thiele; Veronica Veschi
deleteShare
deleteSave
PXDN regulated by WTAP/YTHDF1-mediated m6A modification activates PI3K/AKT signaling pathway through extracellular matrix remodeling to promote progression in nasopharyngeal carcinoma
delete2025-12-18
delete0
deleteOAAI
deleteYing Li; Zongwei Huang; Xingwu Huang; Wanzun Lin; Qin Ding; Wankai Fu; Ronghui Chen; Jinghua Lai; Jianmin Wang; Qinying Liu; Sufang Qiu
deleteShare
deleteSave
Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells
delete2025-12-18
delete0
deleteOAAI
deleteRuoyang Liu; Long Zhang; Guoqing Xie; Xiang Li; Yu Liu; Ningyang Li; Aravind Raveendran; Yuankang Feng; Fubo Lu; Xiyue Deng; Junyi Li; Jinjian Yang; Zhenlin Huang; Zhankui Jia
deleteShare
deleteSave
Targeting TRIM59 impairs RNA splicing and promotes neuroblastoma differentiation and therapeutic responses
delete2025-12-18
delete0
deleteOAAI
deleteYingwen Zhang; Yi Yang; Guoyu Chen; Minzhi Yin; Yijin Gao; Yanxin Li; Haizhong Feng
deleteShare
deleteSave
COX-2/PGE2 axis blockade with celecoxib enhances anti-PD-1 efficacy by activating natural killer cells for residual hepatocellular carcinoma after radiofrequency ablation
delete2025-12-17
delete0
deleteOAAI
deleteYu Lei; Yaowei Bai; Xiatong Bai; Bo Sun; Licheng Zhu; Wenlong Wu; Yang Su; Hongsen Zhang; Yingliang Wang; Chuansheng Zheng
deleteShare
deleteSave
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity
delete2025-12-17
delete0
deleteOAAI
deleteCélia Bienassis; Omar I. Vivar; Yun Hu; Jordan Da silva; Audrey Darmon; Julie Marill; Naeemunnisa Mohamed Anesary; Peter Schmitt; Laurent Levy; James Welsh; Yolanda Prezado; Frédérique Megnin-Chanet; Sébastien Paris
deleteShare
deleteSave
HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation
delete2025-12-17
delete0
deleteOAAI
deleteGuanghui Xu; Shuo Liang; Ganlin Hu; Wei Zhao; Yuqin Li; Minghao Zheng; Zhigang Wu; Tianlei Xie; Shuting Fang; Shan Peng; Yongming Deng; Yihua Zhou; Hongqian Guo; Junlong Zhuang; Wenli Diao
deleteShare
deleteSave
Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair
delete2025-12-14
delete0
deleteOAAI
deleteXiaojian Ni; Min Li; Wenqing Qiu; Jichang Han; Meng Yu; Shulong Zhang; Bohao Zheng; Jiaqi He; Houbao Liu
deleteShare
deleteSave
Targeting ATR offers multifaceted treatment strategies involving RAD51-mediated compensatory DNA repair in bladder cancer
delete2025-12-12
delete0
deleteOAAI
deleteJulia Pannhausen; Ahmed A. Chughtai; Cem-Louis Yüce; Michael K. Melzer; Yanchun Ma; Lancelot Seillier; Emiel P. C. van der Vorst; Geoffroy Andrieux; Julia Wirtz; Sophie Leypold; Mark P. Kühnel; Per Hoffmann; Stefanie Heilmann-Heimbach; Melanie Boerries; Alexander Kleger; Matthias Saar; Michael J. Eble; Danny D. Jonigk; Nadine T. Gaisa; Michael Rose
deleteShare
deleteSave